Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia
Our study aimed to review the impact of COVID-19 pandemia in children and adolescents with type 1 diabetes mellitus, to analyze the clinical characteristics of the infection and to propose clinical practice recommendations from the Italian Society for Pediatric Endocrinology and Diabetology (ISPED)....
Gespeichert in:
| Veröffentlicht in: | Diabetes research and clinical practice 2020-10, Vol.168, p.108372-108372, Article 108372 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 108372 |
|---|---|
| container_issue | |
| container_start_page | 108372 |
| container_title | Diabetes research and clinical practice |
| container_volume | 168 |
| creator | d'Annunzio, Giuseppe Maffeis, Claudio Cherubini, Valentino Rabbone, Ivana Scaramuzza, Andrea Schiaffini, Riccardo Minuto, Nicola Piccolo, Gianluca Maghnie, Mohamad |
| description | Our study aimed to review the impact of COVID-19 pandemia in children and adolescents with type 1 diabetes mellitus, to analyze the clinical characteristics of the infection and to propose clinical practice recommendations from the Italian Society for Pediatric Endocrinology and Diabetology (ISPED).
A literature search was carried out in the guideline databases, Medline and Embase and in Diabetes Societies websites until May 21st, 2020 for guidelines and recommendations on type 1 diabetes mellitus management during COVID-19 pandemic.
COVID-19 infection in pediatric patients seems to be clinically less severe than in adults; children have so far accounted for 1–5% of diagnosed cases, with a median age of 6.7 years (1 day–15 years) and better prognosis. Clinical manifestations include mild, moderate, severe disease up to critical illness. There is currently no evidence suggesting a higher risk of COVID-19 infection in children with diabetes than unaffected peers. Besides general recommendations for pediatric patients, ISPED has proposed specific measures for patients with diabetes.
COVID-19 outbreak modified type 1 diabetes management, and telemedicine has been demonstrating to be an effective new tool for patients care. Moreover psychological aspects deserve attention and future researchs are mandatory. |
| doi_str_mv | 10.1016/j.diabres.2020.108372 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7438223</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168822720306252</els_id><sourcerecordid>2436401228</sourcerecordid><originalsourceid>FETCH-LOGICAL-c519t-b5fecd4a14b81b2a8d26092137a29e2ef7d6c50903eec879d2dccc36193d8f373</originalsourceid><addsrcrecordid>eNqFkcuO0zAYhSMEYsrAI4C8HBYpvuTKAoTaApVGmpEG2FqO_ad15cQd2xnUV-IpcZIyghUr385_jnW-JHlN8JJgUrw7LJUWjQO_pJiOdxUr6ZNkQaqSphWl5dNkEXXVtL9IXnh_wBgXLMufJxeMVrTM62yR_FoJp_sdaq1Dcq-NctAj0SsklDXgJfTBo5867FE4HQERNKZCAI86MEaHwb9H2yCMFj26s1JDOE1etxCFwWmJNr2yMmZYY3enyXo9Wcznq-3d7Wb9FvkgAnRTmhqmH61ufmzXKanRMc5Ap8XL5FkrjIdX5_Uy-f558231Nb2--bJdfbpOZU7qkDZ5C1JlgmRNRRoqKkULXFPCSkFroNCWqpA5rjEDkFVZK6qklKwgNVNVy0p2mXyYfY9D04EaK3DC8KPTnXAnboXm_770es939oGXGYtls2hwdTZw9n4AH3inY5PGiB7s4DnNWJFhQmkVpfkslc5676B9jCGYj5z5gZ8585EznznHuTd___Fx6g_YKPg4CyA29aDBcR_h9DJicSADV1b_J-I3fd2_YQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2436401228</pqid></control><display><type>article</type><title>Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia</title><source>MEDLINE</source><source>ScienceDirect</source><creator>d'Annunzio, Giuseppe ; Maffeis, Claudio ; Cherubini, Valentino ; Rabbone, Ivana ; Scaramuzza, Andrea ; Schiaffini, Riccardo ; Minuto, Nicola ; Piccolo, Gianluca ; Maghnie, Mohamad</creator><creatorcontrib>d'Annunzio, Giuseppe ; Maffeis, Claudio ; Cherubini, Valentino ; Rabbone, Ivana ; Scaramuzza, Andrea ; Schiaffini, Riccardo ; Minuto, Nicola ; Piccolo, Gianluca ; Maghnie, Mohamad</creatorcontrib><description>Our study aimed to review the impact of COVID-19 pandemia in children and adolescents with type 1 diabetes mellitus, to analyze the clinical characteristics of the infection and to propose clinical practice recommendations from the Italian Society for Pediatric Endocrinology and Diabetology (ISPED).
A literature search was carried out in the guideline databases, Medline and Embase and in Diabetes Societies websites until May 21st, 2020 for guidelines and recommendations on type 1 diabetes mellitus management during COVID-19 pandemic.
COVID-19 infection in pediatric patients seems to be clinically less severe than in adults; children have so far accounted for 1–5% of diagnosed cases, with a median age of 6.7 years (1 day–15 years) and better prognosis. Clinical manifestations include mild, moderate, severe disease up to critical illness. There is currently no evidence suggesting a higher risk of COVID-19 infection in children with diabetes than unaffected peers. Besides general recommendations for pediatric patients, ISPED has proposed specific measures for patients with diabetes.
COVID-19 outbreak modified type 1 diabetes management, and telemedicine has been demonstrating to be an effective new tool for patients care. Moreover psychological aspects deserve attention and future researchs are mandatory.</description><identifier>ISSN: 0168-8227</identifier><identifier>EISSN: 1872-8227</identifier><identifier>DOI: 10.1016/j.diabres.2020.108372</identifier><identifier>PMID: 32827594</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Adolescent ; Age of Onset ; Betacoronavirus ; Child ; Child, Preschool ; Clinical recommendations ; Clinical research ; Coronavirus Infections - epidemiology ; COVID-19 ; COVID-19 pandemia ; Diabetes Mellitus, Type 1 - epidemiology ; Diabetes Mellitus, Type 1 - therapy ; Endocrinology - organization & administration ; Endocrinology - standards ; Female ; Humans ; Infant ; Infant, Newborn ; Infectious disease ; Italy - epidemiology ; Male ; Pandemics ; Pediatric age group ; Pneumonia, Viral - epidemiology ; Review ; SARS-CoV-2 ; Societies, Medical ; Telemedicine - organization & administration ; Telemedicine - standards ; Type 1 diabetes mellitus</subject><ispartof>Diabetes research and clinical practice, 2020-10, Vol.168, p.108372-108372, Article 108372</ispartof><rights>2020</rights><rights>Copyright © 2020. Published by Elsevier B.V.</rights><rights>2020 Published by Elsevier B.V. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c519t-b5fecd4a14b81b2a8d26092137a29e2ef7d6c50903eec879d2dccc36193d8f373</citedby><cites>FETCH-LOGICAL-c519t-b5fecd4a14b81b2a8d26092137a29e2ef7d6c50903eec879d2dccc36193d8f373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.diabres.2020.108372$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,777,781,882,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32827594$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>d'Annunzio, Giuseppe</creatorcontrib><creatorcontrib>Maffeis, Claudio</creatorcontrib><creatorcontrib>Cherubini, Valentino</creatorcontrib><creatorcontrib>Rabbone, Ivana</creatorcontrib><creatorcontrib>Scaramuzza, Andrea</creatorcontrib><creatorcontrib>Schiaffini, Riccardo</creatorcontrib><creatorcontrib>Minuto, Nicola</creatorcontrib><creatorcontrib>Piccolo, Gianluca</creatorcontrib><creatorcontrib>Maghnie, Mohamad</creatorcontrib><title>Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia</title><title>Diabetes research and clinical practice</title><addtitle>Diabetes Res Clin Pract</addtitle><description>Our study aimed to review the impact of COVID-19 pandemia in children and adolescents with type 1 diabetes mellitus, to analyze the clinical characteristics of the infection and to propose clinical practice recommendations from the Italian Society for Pediatric Endocrinology and Diabetology (ISPED).
A literature search was carried out in the guideline databases, Medline and Embase and in Diabetes Societies websites until May 21st, 2020 for guidelines and recommendations on type 1 diabetes mellitus management during COVID-19 pandemic.
COVID-19 infection in pediatric patients seems to be clinically less severe than in adults; children have so far accounted for 1–5% of diagnosed cases, with a median age of 6.7 years (1 day–15 years) and better prognosis. Clinical manifestations include mild, moderate, severe disease up to critical illness. There is currently no evidence suggesting a higher risk of COVID-19 infection in children with diabetes than unaffected peers. Besides general recommendations for pediatric patients, ISPED has proposed specific measures for patients with diabetes.
COVID-19 outbreak modified type 1 diabetes management, and telemedicine has been demonstrating to be an effective new tool for patients care. Moreover psychological aspects deserve attention and future researchs are mandatory.</description><subject>Adolescent</subject><subject>Age of Onset</subject><subject>Betacoronavirus</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Clinical recommendations</subject><subject>Clinical research</subject><subject>Coronavirus Infections - epidemiology</subject><subject>COVID-19</subject><subject>COVID-19 pandemia</subject><subject>Diabetes Mellitus, Type 1 - epidemiology</subject><subject>Diabetes Mellitus, Type 1 - therapy</subject><subject>Endocrinology - organization & administration</subject><subject>Endocrinology - standards</subject><subject>Female</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infectious disease</subject><subject>Italy - epidemiology</subject><subject>Male</subject><subject>Pandemics</subject><subject>Pediatric age group</subject><subject>Pneumonia, Viral - epidemiology</subject><subject>Review</subject><subject>SARS-CoV-2</subject><subject>Societies, Medical</subject><subject>Telemedicine - organization & administration</subject><subject>Telemedicine - standards</subject><subject>Type 1 diabetes mellitus</subject><issn>0168-8227</issn><issn>1872-8227</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcuO0zAYhSMEYsrAI4C8HBYpvuTKAoTaApVGmpEG2FqO_ad15cQd2xnUV-IpcZIyghUr385_jnW-JHlN8JJgUrw7LJUWjQO_pJiOdxUr6ZNkQaqSphWl5dNkEXXVtL9IXnh_wBgXLMufJxeMVrTM62yR_FoJp_sdaq1Dcq-NctAj0SsklDXgJfTBo5867FE4HQERNKZCAI86MEaHwb9H2yCMFj26s1JDOE1etxCFwWmJNr2yMmZYY3enyXo9Wcznq-3d7Wb9FvkgAnRTmhqmH61ufmzXKanRMc5Ap8XL5FkrjIdX5_Uy-f558231Nb2--bJdfbpOZU7qkDZ5C1JlgmRNRRoqKkULXFPCSkFroNCWqpA5rjEDkFVZK6qklKwgNVNVy0p2mXyYfY9D04EaK3DC8KPTnXAnboXm_770es939oGXGYtls2hwdTZw9n4AH3inY5PGiB7s4DnNWJFhQmkVpfkslc5676B9jCGYj5z5gZ8585EznznHuTd___Fx6g_YKPg4CyA29aDBcR_h9DJicSADV1b_J-I3fd2_YQ</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>d'Annunzio, Giuseppe</creator><creator>Maffeis, Claudio</creator><creator>Cherubini, Valentino</creator><creator>Rabbone, Ivana</creator><creator>Scaramuzza, Andrea</creator><creator>Schiaffini, Riccardo</creator><creator>Minuto, Nicola</creator><creator>Piccolo, Gianluca</creator><creator>Maghnie, Mohamad</creator><general>Elsevier B.V</general><general>Published by Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201001</creationdate><title>Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia</title><author>d'Annunzio, Giuseppe ; Maffeis, Claudio ; Cherubini, Valentino ; Rabbone, Ivana ; Scaramuzza, Andrea ; Schiaffini, Riccardo ; Minuto, Nicola ; Piccolo, Gianluca ; Maghnie, Mohamad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c519t-b5fecd4a14b81b2a8d26092137a29e2ef7d6c50903eec879d2dccc36193d8f373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Age of Onset</topic><topic>Betacoronavirus</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Clinical recommendations</topic><topic>Clinical research</topic><topic>Coronavirus Infections - epidemiology</topic><topic>COVID-19</topic><topic>COVID-19 pandemia</topic><topic>Diabetes Mellitus, Type 1 - epidemiology</topic><topic>Diabetes Mellitus, Type 1 - therapy</topic><topic>Endocrinology - organization & administration</topic><topic>Endocrinology - standards</topic><topic>Female</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infectious disease</topic><topic>Italy - epidemiology</topic><topic>Male</topic><topic>Pandemics</topic><topic>Pediatric age group</topic><topic>Pneumonia, Viral - epidemiology</topic><topic>Review</topic><topic>SARS-CoV-2</topic><topic>Societies, Medical</topic><topic>Telemedicine - organization & administration</topic><topic>Telemedicine - standards</topic><topic>Type 1 diabetes mellitus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>d'Annunzio, Giuseppe</creatorcontrib><creatorcontrib>Maffeis, Claudio</creatorcontrib><creatorcontrib>Cherubini, Valentino</creatorcontrib><creatorcontrib>Rabbone, Ivana</creatorcontrib><creatorcontrib>Scaramuzza, Andrea</creatorcontrib><creatorcontrib>Schiaffini, Riccardo</creatorcontrib><creatorcontrib>Minuto, Nicola</creatorcontrib><creatorcontrib>Piccolo, Gianluca</creatorcontrib><creatorcontrib>Maghnie, Mohamad</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes research and clinical practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>d'Annunzio, Giuseppe</au><au>Maffeis, Claudio</au><au>Cherubini, Valentino</au><au>Rabbone, Ivana</au><au>Scaramuzza, Andrea</au><au>Schiaffini, Riccardo</au><au>Minuto, Nicola</au><au>Piccolo, Gianluca</au><au>Maghnie, Mohamad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia</atitle><jtitle>Diabetes research and clinical practice</jtitle><addtitle>Diabetes Res Clin Pract</addtitle><date>2020-10-01</date><risdate>2020</risdate><volume>168</volume><spage>108372</spage><epage>108372</epage><pages>108372-108372</pages><artnum>108372</artnum><issn>0168-8227</issn><eissn>1872-8227</eissn><abstract>Our study aimed to review the impact of COVID-19 pandemia in children and adolescents with type 1 diabetes mellitus, to analyze the clinical characteristics of the infection and to propose clinical practice recommendations from the Italian Society for Pediatric Endocrinology and Diabetology (ISPED).
A literature search was carried out in the guideline databases, Medline and Embase and in Diabetes Societies websites until May 21st, 2020 for guidelines and recommendations on type 1 diabetes mellitus management during COVID-19 pandemic.
COVID-19 infection in pediatric patients seems to be clinically less severe than in adults; children have so far accounted for 1–5% of diagnosed cases, with a median age of 6.7 years (1 day–15 years) and better prognosis. Clinical manifestations include mild, moderate, severe disease up to critical illness. There is currently no evidence suggesting a higher risk of COVID-19 infection in children with diabetes than unaffected peers. Besides general recommendations for pediatric patients, ISPED has proposed specific measures for patients with diabetes.
COVID-19 outbreak modified type 1 diabetes management, and telemedicine has been demonstrating to be an effective new tool for patients care. Moreover psychological aspects deserve attention and future researchs are mandatory.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>32827594</pmid><doi>10.1016/j.diabres.2020.108372</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0168-8227 |
| ispartof | Diabetes research and clinical practice, 2020-10, Vol.168, p.108372-108372, Article 108372 |
| issn | 0168-8227 1872-8227 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7438223 |
| source | MEDLINE; ScienceDirect |
| subjects | Adolescent Age of Onset Betacoronavirus Child Child, Preschool Clinical recommendations Clinical research Coronavirus Infections - epidemiology COVID-19 COVID-19 pandemia Diabetes Mellitus, Type 1 - epidemiology Diabetes Mellitus, Type 1 - therapy Endocrinology - organization & administration Endocrinology - standards Female Humans Infant Infant, Newborn Infectious disease Italy - epidemiology Male Pandemics Pediatric age group Pneumonia, Viral - epidemiology Review SARS-CoV-2 Societies, Medical Telemedicine - organization & administration Telemedicine - standards Type 1 diabetes mellitus |
| title | Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T18%3A56%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Caring%20for%20children%20and%20adolescents%20with%20type%201%20diabetes%20mellitus:%20Italian%20Society%20for%20Pediatric%20Endocrinology%20and%20Diabetology%20(ISPED)%20statements%20during%20COVID-19%20pandemia&rft.jtitle=Diabetes%20research%20and%20clinical%20practice&rft.au=d'Annunzio,%20Giuseppe&rft.date=2020-10-01&rft.volume=168&rft.spage=108372&rft.epage=108372&rft.pages=108372-108372&rft.artnum=108372&rft.issn=0168-8227&rft.eissn=1872-8227&rft_id=info:doi/10.1016/j.diabres.2020.108372&rft_dat=%3Cproquest_pubme%3E2436401228%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2436401228&rft_id=info:pmid/32827594&rft_els_id=S0168822720306252&rfr_iscdi=true |